One License for Two Therapeutic Antibody Discovery Platforms
Biocytogen’s RenMab™ and RenLite™ humanized mice are powerful platforms for fully human therapeutic antibody discovery. The RenMab™ model, our best-in-class humanized antibody mouse, is ideal for the discovery of fully human therapeutic antibodies. The RenLite™ mouse model is specially designed for bispecific and multispecific antibody discovery, as the common light chain eliminates chain mispairing issues during bispecific antibody development. These humanized antibody mice allow for natural in vivo selection and affinity maturation, ensuring maximum developability and minimum immunogenicity of your anti-human therapeutic antibody.
One license covers use of both humanized antibody mouse platforms.